Reactome: A Curated Pathway Database
THIS SITE IS USED FOR CURATION AND TESTING
IT IS NOT STABLE, IS LINKED TO AN INCOMPLETE DATA SET, AND IS NOT MONITORED FOR PERFORMANCE. WE STRONGLY RECOMMEND THE USE OF OUR PUBLIC SITE

Query author contributions in Reactome

Reactome depends on collaboration between our curation team and outside experts to assemble and peer-review its pathway modules. The integration of ORCID within Reactome enables us to meet a key challenge with authoring, curating and reviewing biological information by incentivizing and crediting the external experts that contribute their expertise and time to the Reactome curation process. More information is available at ORCID and Reactome.

If you have an ORCID ID that is not listed on this page, please forward this information to us and we will update your Reactome pathway records.

Name Email address

Details on Person Baylin, Stephen B

Class:IdPerson:5665629
_displayNameBaylin, Stephen B
_timestamp2015-01-19 11:46:15
created[InstanceEdit:5665619] Garapati, P V, 2015-01-19
firstnameStephen B
initialSB
surnameBaylin
(author)[LiteratureReference:5665632] Epigenetic inactivation of the canonical Wnt antagonist SRY-box containing gene 17 in colorectal cancer
[LiteratureReference:9634000] 5' CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers
[LiteratureReference:9634012] Inactivation of the CDKN2/p16/MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancers
[Change default viewing format]
No pathways have been reviewed or authored by Baylin, Stephen B (5665629)